Anti-CD20 therapy

Clinical trials for Anti-CD20 therapy explained in plain language.

Never miss a new study

Get alerted when new Anti-CD20 therapy trials appear

Sign up with your email to follow new studies for Anti-CD20 therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

MS breakthrough? trial tests if older patients can ditch heavy drugs

Disease control Recruiting now

This study looks at whether people with relapsing-remitting multiple sclerosis (RRMS) who are over 40 and have been stable on strong anti-CD20 drugs for at least 3 years can safely switch to milder treatments. The goal is to see if this de-escalation approach prevents disease act…

Matched conditions: ANTI-CD20 THERAPY

Phase 3 • Sponsor: University Hospital, Montpellier • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

Anti-CD20 therapy

Get alerted when new Anti-CD20 therapy trials appear

MS breakthrough? trial tests if older patients can ditch heavy drugs